Heart failure trials recruiting in Texas

All Heart failure trials nationally

Cities in Texas

Recruiting trials in Texas

• 18F-mFBG Imaging for Myocardial Sympathetic Innervation
  NCT06965621 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
  NCT03394365 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas, Houston
• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
  NCT05489705 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Plano, Temple
• A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
  NCT06979362 · Phase: Phase 2 · Ages: 40 Years to 84 Years · Sex: All (male and female) · Texas: Amarillo, Dallas, Denison, Houston
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Conroe, Corpus Christi
• A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
  NCT07219511 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · Texas: Dallas, Tomball
• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · Texas: Dallas, Houston
• A Study of LY3971297 in Participants With Heart Failure
  NCT07547540 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Houston
• A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
  NCT06056297 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Texas: Dallas, Fort Worth, Houston, Woodland
• A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
  NCT06024746 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Denison, Fort Worth
• A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
  NCT06008197 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Dallas, Houston
• A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
  NCT06033950 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Denison, Houston, Tyler
• A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
  NCT07761117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, DeSoto, El Paso, Houston
• A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
  NCT06991257 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Texas: Brownsville, McKinney, Tomball
• A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07192952 · Phase: Phase 3 · Ages: Up to 18 Years · Sex: All (male and female) · Texas: Dallas, Houston
• A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07188805 · Phase: Phase 3 · Ages: 6 Months to 17 Years · Sex: All (male and female) · Texas: Dallas, Houston
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Beaumont, Cypress, Dallas
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
  NCT06424288 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Dallas, Fort Worth, Katy
• AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
  NCT06699056 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Weslaco
• AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
  NCT06793371 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Texas: Dallas, Houston
• AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
  NCT06378632 · Phase: Not specified · Ages: 22 Years and older · Sex: All (male and female) · Texas: McAllen, San Antonio
• Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
  NCT06108076 · Phase: Early Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio
• Alleviant ALLAY-HF Study
  NCT05685303 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Texas: Abilene, Austin, Dallas, Plano
• Alleviant ALLAY-HFrEF Study
  NCT06812533 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Abilene, Austin, Plano, Temple
• Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
  NCT06655376 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, Fort Worth, Houston
• Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
  NCT07232030 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Tyler
• BiVACOR® Total Artificial Heart Early Feasibility Study
  NCT06174103 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: Houston
• CALM Study: Cardiomems Assisted Lvad Management
  NCT07096544 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 85 Years · Sex: All (male and female) · Texas: Plano
• CCM OPEN HF Registry
  NCT07112924 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: El Paso, Tyler
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  NCT07207811 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, Houston, Plano
• CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
  NCT05996328 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Texas: Dallas, Houston
• Cardiogenic Shock Working Group Registry
  NCT04682483 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Galveston, Houston
• Cardiopulmonary Stress Testing (CPET) AlloSure Study
  NCT04656080 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Beaumont, Dallas, El Paso
• Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
  NCT06964464 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Tyler
• Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
  NCT05677100 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · Texas: Fort Worth, Houston, Plano
• ELEVATE-HFpEF Clinical Study
  NCT06678841 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Texas: Dallas, Fort Worth
• Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
  NCT01790152 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas, Fort Worth, Houston, San Antonio
• Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
  NCT06130059 · Phase: Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · Texas: Dallas
• Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
  NCT05714085 · Phase: Phase 2, Phase 3 · Ages: 29 Days to 17 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
  NCT06898515 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · Texas: Dallas, Houston
• Get With The Guidelines-Heart Failure Registry
  NCT02693509 · Phase: Not specified · Ages: 18 Years to 125 Years · Sex: All (male and female) · Texas: Dallas
• HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
  NCT04149743 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Texas: Temple
• HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
  NCT06425848 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Texas: Austin, Houston
• HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
  NCT06659952 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Home-based Cardiac Rehabilitation in Heart Failure
  NCT06349941 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• IEEM-Heat and Heart Failure
  NCT06961929 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · Texas: Dallas
• Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
  NCT01258231 · Phase: Not specified · Ages: 20 Years to 90 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
  NCT06310031 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · Texas: Dallas, Houston, Plano
• Ketones, SGLT2, HFrEF
  NCT06229678 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
  NCT07288398 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Texas: Austin, Dallas, El Paso, Houston
• Left vs Left Randomized Clinical Trial
  NCT05650658 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Arlington, Houston
• MYTHS - MYocarditis THerapy With Steroids
  NCT05150704 · Phase: Phase 3 · Ages: 18 Years to 69 Years · Sex: All (male and female) · Texas: Houston
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Conroe, Dallas
• Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction
  NCT06061549 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · Texas: Dallas
• Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
  NCT04703842 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Dallas
• Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
  NCT06080074 · Phase: Phase 2 · Ages: 0 Years to 16 Years · Sex: All (male and female) · Texas: Dallas
• NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
  NCT06593327 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas
• Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
  NCT07436299 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
  NCT06939751 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Dallas
• Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
  NCT06532890 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · Texas: Houston
• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
  NCT05934487 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, Houston, San Antonio
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · Texas: Abilene, Austin, Beaumont, Brownsville
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
  NCT05838287 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• Polypill for Prevention of Cardiomyopathy
  NCT06143566 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Texas: Dallas
• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  NCT00271180 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Austin, Dallas, Fort Worth, Houston
• REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
  NCT06777368 · Phase: Not specified · Ages: 18 Years to 105 Years · Sex: All (male and female) · Texas: Austin, Houston, San Antonio
• Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
  NCT06360380 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 79 Years · Sex: All (male and female) · Texas: Austin
• Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
  NCT04982419 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
  NCT05057806 · Phase: Early Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio
• Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
  NCT07069738 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Plano, Tyler
• Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
  NCT05056129 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · Texas: Austin
• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
  NCT06217302 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · Texas: Dallas, Miami, San Antonio
• Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
  NCT06831825 · Phase: Phase 1 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Texas: Houston
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Texas: Dallas, El Paso, Galveston, Houston
• Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
  NCT06560762 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · Texas: Allen, Amarillo, Cypress, Dallas
• TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
  NCT06137807 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Tailored Exercise Training Study Among Adults With HFpEF
  NCT07223242 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF
  NCT05723679 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 90 Years · Sex: All (male and female) · Texas: Dallas
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
  NCT03142152 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• The Hepatitis C Transplant Collaborative
  NCT04493385 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• The ROle of Compression StocKings in Heart Failure Patients
  NCT06350695 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
  NCT03383419 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: All (male and female) · Texas: Dallas
• Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
  NCT07221851 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Texas: Edinburg, Fort Worth, San Antonio
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, Houston, Plano
• Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
  NCT06641362 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
  NCT06593314 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas
• XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
  NCT06895070 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas